DUBLIN, Ireland--(BUSINESS WIRE)--ICON (NASDAQ:ICLR) (ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced its payment or issuance date, and the NASDAQ ex-date for its bonus issue of ADSs.
